Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Community-acquired pneumonia: can it be defined with claims data?

Whittle J, Fine MJ, Joyce DZ, Lave JR, Young WW, Hough LJ, Kapoor WN.

Am J Med Qual. 1997 Winter;12(4):187-93.

PMID:
9385729
2.

Accuracy of administrative data for identifying patients with pneumonia.

Aronsky D, Haug PJ, Lagor C, Dean NC.

Am J Med Qual. 2005 Nov-Dec;20(6):319-28.

PMID:
16280395
3.

Identifying pediatric community-acquired pneumonia hospitalizations: Accuracy of administrative billing codes.

Williams DJ, Shah SS, Myers A, Hall M, Auger K, Queen MA, Jerardi KE, McClain L, Wiggleton C, Tieder JS.

JAMA Pediatr. 2013 Sep;167(9):851-8.

4.

Classification algorithms to improve the accuracy of identifying patients hospitalized with community-acquired pneumonia using administrative data.

Yu O, Nelson JC, Bounds L, Jackson LA.

Epidemiol Infect. 2011 Sep;139(9):1296-306. doi: 10.1017/S0950268810002529. Epub 2010 Nov 19.

PMID:
21087538
5.

Quality of care delivered by fee-for-service and DRG hospitals in Switzerland in patients with community-acquired pneumonia.

Schuetz P, Albrich WC, Suter I, Hug BL, Christ-Crain M, Holler T, Henzen C, Krause M, Schoenenberger R, Zimmerli W, Mueller B.

Swiss Med Wkly. 2011 Jul 18;141:w13228. doi: 10.4414/smw.2011.13228.

6.

International classification of diseases codes showed modest sensitivity for detecting community-acquired pneumonia.

van de Garde EM, Oosterheert JJ, Bonten M, Kaplan RC, Leufkens HG.

J Clin Epidemiol. 2007 Aug;60(8):834-8. Epub 2007 Feb 23.

PMID:
17606180
7.

The evaluation of screening methods to identify medically unnecessary hospital stay for patients with pneumonia.

Hartz AJ, Bade PF, Sigmann P, Guse C, Epple P, Goldberg KC.

Int J Qual Health Care. 1996 Feb;8(1):3-11.

PMID:
8680814
8.

Does severity explain differences in hospital length of stay for pneumonia patients?

Iezzoni LI, Shwartz M, Ash AS, Mackiernan YD.

J Health Serv Res Policy. 1996 Apr;1(2):65-76.

PMID:
10180852
9.

Factors influencing length of hospital stay in community-acquired pneumonia: a study in 27 community hospitals.

Cabre M, Bolivar I, Pera G, Pallares R; Pneumonia Study Collaborative Group.

Epidemiol Infect. 2004 Oct;132(5):821-9.

10.

Adherence to ATS guidelines for hospitalized patients with community-acquired pneumonia.

Malone DC, Shaban HM.

Ann Pharmacother. 2001 Oct;35(10):1180-5.

PMID:
11675841
11.

Socioeconomic status and hospital utilization among younger adult pneumonia admissions at a Canadian hospital.

McGregor MJ, Reid RJ, Schulzer M, Fitzgerald JM, Levy AR, Cox MB.

BMC Health Serv Res. 2006 Nov 25;6:152.

12.

A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.

Schein J, Janagap-Benson C, Grant R, Sikirica V, Doshi D, Olson W.

Curr Med Res Opin. 2008 Mar;24(3):895-906. doi: 10.1185/030079908X273408.

PMID:
18419876
13.

Factors influencing patients' length of stay.

Liu Y, Phillips M, Codde J.

Aust Health Rev. 2001;24(2):63-70.

PMID:
11496473
14.

Validation of a predictive rule for the management of community-acquired pneumonia.

Capelastegui A, EspaƱa PP, Quintana JM, Areitio I, Gorordo I, Egurrola M, Bilbao A.

Eur Respir J. 2006 Jan;27(1):151-7.

15.

Racial variations in processes of care for patients with community-acquired pneumonia.

Mortensen EM, Cornell J, Whittle J.

BMC Health Serv Res. 2004 Aug 10;4(1):20.

16.

Experiences at a large teaching hospital with levofloxacin for the treatment of community-acquired pneumonia.

Clark LC, Davis CW.

Am J Health Syst Pharm. 2000 Nov 15;57 Suppl 3:S10-3.

PMID:
11098314
17.

Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes?

McCormick D, Fine MJ, Coley CM, Marrie TJ, Lave JR, Obrosky DS, Kapoor WN, Singer DE.

Am J Med. 1999 Jul;107(1):5-12.

PMID:
10403346
18.

Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: a US-based study.

Frei CR, Jaso TC, Mortensen EM, Restrepo MI, Raut MK, Oramasionwu CU, Ruiz AD, Makos BR, Ruiz JL, Attridge RT, Mody SH, Fisher A, Schein JR.

Curr Med Res Opin. 2009 Apr;25(4):859-68. doi: 10.1185/03007990902779749 .

PMID:
19231913
19.

Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study.

Johnstone J, Eurich DT, Majumdar SR, Jin Y, Marrie TJ.

Medicine (Baltimore). 2008 Nov;87(6):329-34. doi: 10.1097/MD.0b013e318190f444.

20.

Assessing the burden of pneumonia using administrative data from Malaysia, Indonesia, and the Philippines.

Azmi S, Aljunid SM, Maimaiti N, Ali AA, Muhammad Nur A, De Rosas-Valera M, Encluna J, Mohamed R, Wibowo B, Komaryani K, Roberts C.

Int J Infect Dis. 2016 Aug;49:87-93. doi: 10.1016/j.ijid.2016.05.021. Epub 2016 May 24.

Supplemental Content

Support Center